Skip to main content

UBS Group AG

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in EWTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,108,908
-$34,191,529 QoQ
Shares Held
174,967
-86.7% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 223 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. EWTX ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,108,908 174,967
2026-03-31 $41,300,437 1,311,125
2025-12-31 $52,535,166 2,117,073
2025-09-30 $1,851,155 114,128
2025-06-30 $2,241,573 170,982
2025-03-31 $5,365,712 243,896
2024-12-31 $2,458,162 92,066
2024-09-30 $2,009,889 75,305
2024-06-30 $1,089,784 60,510
2024-03-31 $1,351,911 74,118
2022-12-31 $13,865 1,551
2022-03-31 $213,855 22,047
2021-06-30 $18,514 868